Loading...
BYH to folks that don’t move over or get out of the way for emergency vehicles. One day it might be your relative they...

Welcome competition should lower EpiPen prices

CVS-EpiPen Generic

A rival generic version of Mylan's EpiPen has been approved for sale at about a sixth of its price, just months after the maker of the emergency allergy treatment was eviscerated before Congress because of its soaring cost to consumers.

Loading…

Friday, August 24, 2018

A couple of years ago Washington fell into anaphylactic shock over the high cost of EpiPens, devices that shoot adrenaline into someone having an allergic reaction. But the Trump Administration this week injected some overdue competition into the market that could lower prices for millions of Americans.

On Thursday the Food and Drug Administration approved the first generic competitor to Mylan ‘s EpiPen. The competing drug is manufactured by the Israeli pharmaceutical company Teva. One might wonder why a simple spring device filled with a cheap medicine didn’t have competitors, even decades after invention.

That was one question in 2016, when Congress hauled in Mylan CEO Heather Bresch to register outrage about the more than $600 list price of a two-pack of pens, which millions of kids and adults have to keep on hand. Not everyone pays full price after rebates and discounts, and some of the shock came from insurance designs that increased out-of-pocket costs. But the sticker price had increased more than 500 percent over 10 years.

Yet if Mylan kept prices high, the company had help from the FDA. The agency had not articulated standards for a class of drugs known as “complex generics” such as inhalers, which are more fraught than proving similarity to, say, a molecule pill. Mylan thus had no direct competition, though it now sells its own generic copy.

Other injectors are on the market but a pharmacist can’t substitute these versions thanks to issues as minor as the instructions for the device, though there is no clinical distinction. Companies like Teva have spent years ensnared in FDA processes, and in the meantime Mylan could increase prices without market consequences.

Before he became the current FDA Commissioner, Scott Gottlieb told Congress in 2016 about the “Catch-22” for drugmakers: They couldn’t win approval as a generic because another injection device wasn’t exactly the same as EpiPen, but other regulations also make it hard for competitors to get branded alternatives through the FDA’s new drug approval pathway.

Dr. Gottlieb has made clarity for such complex generics a priority at the FDA, and on Thursday he called the Teva device approval part of the agency’s efforts to remove barriers to competition. The approval is particularly timely amid supply shortages of EpiPens.

On all the evidence, products face the sharpest price decline when two generics are competing with the branded version. More drugmakers will jump into a market if they see an opportunity to make money and a regulatory agency that doesn’t construct needless barriers to entry.

At the time of the EpiPen brouhaha, Hillary Clinton called for a federal “consumer response team” that would rove around and penalize companies for price spikes. The laugh-cry moment is that the Trump Administration has flirted with a response from the Clinton playbook: Importing price controls from Europe for drugs with expired patents that lack competition.

President Trump seems to think that drugs are too expensive because of unfettered markets, but the EpiPen episode is a reminder: The real culprit is often not too much freedom but big business exploiting big government to keep prices high.

The Wall Street Journal

Loading…

Humans of Greenville

@HumansofGville

Local photographer Joe Pellegrino explores Greenville to create a photographic census of its people.

Editorials

November 14, 2018

Members of the N.C. General Assembly will get some legislative exercise to help burn off their Thanksgiving calories this year, returning to Raleigh for a late-November special session that will, among other things, write the rules for the state’s newly enacted constitutional requirement for…

Voter ID Lawsuit

November 13, 2018

Anita Earls, who was elected Tuesday to a seat on the N.C. Supreme Court, ought to be happy that legislative Republicans apparently spend so much time reading Niccolo Machiavelli’s 16th century treatise on power, “The Prince.”

Machiavelli urged a style of cunning political…

Supreme Court Earls

November 10, 2018

The Democrats’ return to control over the House of Representatives is much more than a victory for one party. It is a sign of health for American democracy.

Distrustful of untrammeled majorities, the authors of the Constitution favored checks and balances, including, crucially, the check that…

Election 2018 Trump

November 09, 2018

With the courts and Trump Administration rolling back federal climate regulation, green activists have turned to the states. But there’s a troubling ethical twist: Instead of merely lobbying, activists are placing employees in Attorneys General offices in dubious private-public condominiums.…

November 04, 2018

President Trump’s assertion on Tuesday that he could end birthright citizenship via an executive order likely is another attempt to stir up immigration as a campaign issue ahead of next week’s midterm election.

It’s a bad and almost certainly unconstitutional idea, and had the…

AP Explains Birthright Citizenship-2

November 04, 2018

Pitt County is fortunate to have a ballot full of fine candidates running for elected office on Tuesday. Women and men have put their names forth to produce contested races for almost every seat. The races offer contrasts in style, personality and direction.

The Daily Reflector has reported on the…

November 02, 2018

It’s natural to think of worst case scenarios when such a scenario is right before your eyes. So it was Monday when authorities said a Butler High School student was shot and killed by another student during a dispute in a school hallway. The death appeared to be the first fatal shooting…

North Carolina School Shooting-3

October 31, 2018

Children in North Carolina aren’t learning to read fast enough or well enough. The state has invested millions. Hands are wringing, and heads are hitting hard against the wall. “Success” can’t be claimed if a third-grader can’t read the word and know what it means.

And…

101518aydenm

October 30, 2018

The United States has been a beacon of hope for people who are poor, mistreated or persecuted. That is a unique position on the world stage that must not be abdicated.

Many Americans trace their roots to people who left harsh conditions in other countries in search of a better life in the United…

Central America Migrant Caravan

October 26, 2018

In the Trump era, buttoned-down, straight-laced conservatism is widely seen to have been replaced by wild-eyed, open-throated populism. Yet Trump has worked closely with Congress to deliver economic policies that big-business Republicans have wanted for decades. In a strange and important way,…

Financial Markets Wall Street-7
92 stories in Editorials. Viewing 1 through 10.
«First Page   «Previous Page        
Page 1 of 10
        Next Page»   Last Page»